Background and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.

Diabetologia covers Diabetes

Established in 1978 and designed for management of chain drug stores, food-drug combination stores, major wholesalers and manufacturers. Provides timely industry news and in-depth product category analysis. Also publishes in-depth features on health and beauty care categories, general merchandise categories, consumables and retail technology. Regular topics include skin care, first aid, hair care, sun care, foot care, beauty products, diabetes, healthcare appliances, smoking cessation and sports medicine. Includes annual supplements, such as the Teen Supplement, which discusses topics affecting teenagers today and the Skin Care supplement, which covers new trends in skin care products. The Annual RX report, The Top 100 Chain Drug Markets listing, the Annual Wholesale Drug Study, the Small Chain Report and the Annual Sales Survey are also included. Press releases and all inquiries should be sent to Vice President/Editorial Director

Impact factor: 15.432 (2015 two year impact factor) Circulation: Source: Publisher Monthly Unique Users: 36,879 (Source: Publisher) Aims of the journal: In-depth Reviews aims to present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are offered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals. Finally, Case Studies enable authors to present novel and interesting cases and discuss the most useful features to bear in mind for treating future cases. Content: Subjects covered include: Adrenal gland Autoimmunity (including infection) Bone and mineral metabolism Cancer Cardiovascular endocrinology (including endocrine hypertension) Diabetes (including the metabolic syndrome, hyperglycemia, hyperlipidemia) Diagnosis and screening Epidemiology Gastrointestinal hormones (not including pancreatic hormones) Genetics Growth and development (including growth hormone and insulin-like growth factors) Malnutrition Metabolism Multihormonal system disorders Neuroendocrinology (including the hypothalamus) Obesity Other Pancreatic hormones (other than insulin) Parathyroid gland Pediatric endocrinology Pituitary gland (including pineal gland) Reproductive endocrinology (including placental hormones) Surgery (including transplantation and biopsies) Therapy (pharmacotherapy, radiotherapy, nutrition, alternative) Thyroid gland Readership: Targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, they aim to make all our articles accessible to readers working in any medical discipline. According to the publisher: On average, researchers reading Nature Reviews Endocrinology state an annual budget of $79k for products/equipment 58% of Nature Reviews Endocrinology’s clinical audience are Physicians and 22% of those are Endocronologists Manuscript Submission: To be published in Nature Reviews clinical content must meet the following criteria: Timely, accurate and balanced Important to practicing doctors, researchers and academics in the subspecialty Interesting and accessible to practicing doctors, researchers and academics in wider specialties Author instructions can be found here. The journal welcome suggestions and ideas for articles, but discourage the submission of non-commissioned articles. Commissioned articles via online manuscript submission here. Other information: For details of commercial opportunities click here.

Written to provide practical information for clinicians; promotes communication between developers and users of new technology and products, and covers the interface between clinical practice, industry, and government.